why do glp-1 agonists cause nausea and Anesthesia: Considerations and Cautions for CRNAs Clinical Recommendations to Manage Gastrointestinal

Yang W, Chen L, Ji Q, Liu X, Ma J, Tandon N, et al

To view or add a comment, sign in Novartis has entered into an exclusive global #licensing and #collaboration #agreement with SciNeuro Pharmaceuticals to develop and commercialize novel therapies for #Alzheimers disease, in a deal valued at up to USD 1.7 billion

United States Maintains Market Leadership with Commercial Insurance Coverage Demand for obesity GLP-1 treatment in the United States is expanding at a CAGR of 25.4%, driven by growing commercial insurance coverage and strong consumer awareness of available treatments

Weight Loss For individuals struggling with obesity, GLP drugs can help by reducing hunger, making it easier to adhere to a calorie-controlled diet

GLP-1 (Glucagon-Like Peptide-1) is a natural hormone produced in the gut